Item 2.02. Results of Operations and Financial Condition

On January 9, 2023, Augmedix, Inc., a Delaware corporation, announced its preliminary financial results for the fourth quarter ended December 31, 2022. The press release announcing the release of preliminary financial results is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information provided in this Item 2.02, including Exhibit 99.1, is intended to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.



(d)       Exhibits.

Exhibit
  No.                                   Description

99.1        Press release dated January 9, 2023 announcing preliminary fourth
          quarter 2022 financial results.

104       Cover Page Interactive Data File--the cover page XBRL tags are embedded
          within the Inline XBRL document.

© Edgar Online, source Glimpses